Literature DB >> 8566074

Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge.

J N Menon1, P A Bretscher.   

Abstract

BALB/c mice are susceptible to a high-dose infection of the protozoan Leishmania major, which induces a parasite-specific antibody, Th2-like response, exclusive of a significant and protective cell-mediated Th1 component. We have shown, in contrast, that infection with a low number of parasites induces cell-mediated immunity exclusive of antibody production, and results in resistance to substantial subsequent high-dose infection. Low-dose exposure thus constitutes effective vaccination. In the present study, we analyze lymphokine production by parasite-specific T cells from those low-dose exposed, resistant mice and from normal, susceptible mice following high-dose infection. Two findings stand out. First, the parasite-specific T cells in mice rendered resistant appear not to be in an activated, effector state at the time of parasite challenge, as assessed by lack of lymphokine production on short-term stimulation with parasite antigens, but to be rather in a memory state. Second, the ratio of parasite antigen-dependent production of interferon-gamma to that of interleukin-4 by spleen cells of low-dose exposed and normal mice upon high-dose challenge takes a dramatically different course. This ratio is similar in both groups of mice shortly after challenge, but increases dramatically in the resistant and declines dramatically in the control mice over a period of weeks, such that these ratios differ by about 60-fold 12 weeks after the high-dose challenge. In addition, we show that a similar state of resistance occurs following low-dose infection with a more virulent strain of L. major. In toto, our observations suggest that resistance may be generally achievable by low-dose exposure and may be associated with a memory state which, when activated by parasite challenge, results in the evolution of the response over weeks such that the protective, Th1 component becomes ever more dominant over the Th2 component.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8566074     DOI: 10.1002/eji.1830260138

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

1.  C57BL/6 mice are more susceptible to antigen-induced pulmonary eosinophilia than BALB/c mice, irrespective of systemic T helper 1/T helper 2 responses.

Authors:  T Morokata; J Ishikawa; K Ida; T Yamada
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

2.  Effect of low-dose antigen exposure on development of immunity to Helicobacter pylori infection in mice.

Authors:  F J Radcliff; R L Ferrero
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 3.  What roles do regulatory T cells play in the control of the adaptive immune response?

Authors:  Melvin Cohn
Journal:  Int Immunol       Date:  2008-07-25       Impact factor: 4.823

4.  Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route.

Authors:  C A Power; G Wei; P A Bretscher
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

5.  Th1/Th2 cytokine responses following HIV-1 immunization in seronegative volunteers. The AIDS Vaccine Evaluation Group.

Authors:  T G Evans; T Fitzgerald; D C Gibbons; M C Keefer; H Soucier
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

6.  Beryllium, an adjuvant that promotes gamma interferon production.

Authors:  J Y Lee; O Atochina; B King; L Taylor; M Elloso; P Scott; M D Rossman
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

7.  Baculovirus-mediated gene delivery into Mammalian cells does not alter their transcriptional and differentiating potential but is accompanied by early viral gene expression.

Authors:  Christos Kenoutis; Rodica C Efrose; Luc Swevers; Alexandros A Lavdas; Maria Gaitanou; Rebecca Matsas; Kostas Iatrou
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge.

Authors:  Laura Ramírez; Salvador Iborra; Jimena Cortés; Pedro Bonay; Carlos Alonso; Manoel Barral-Netto; Manuel Soto
Journal:  J Biomed Biotechnol       Date:  2010-01-26

Review 9.  Melanoma, Darwinian medicine and the inner world.

Authors:  B Krone; J M Grange
Journal:  J Cancer Res Clin Oncol       Date:  2010-09-18       Impact factor: 4.553

10.  The Leishmania infantum acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to Leishmania major infection in BALB/c mice.

Authors:  Salvador Iborra; Manuel Soto; Javier Carrión; Ana Nieto; Edgar Fernández; Carlos Alonso; Jose M Requena
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.